Displaying drugs 4701 - 4725 of 5128 in total
Deucrictibant
Investigational
D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide
Experimental
Befovacimab
Investigational
ATM-3507
Investigational
Linafexor
Investigational
Edecesertib
Edecesertib is under investigation in clinical trial NCT05629208 (Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE)).
Investigational
Bomedemstat
Investigational
Mezigdomide
Mezigdomide is under investigation in clinical trial NCT05372354 (A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma).
Investigational
SEL-24
Investigational
Chromic citrate
Experimental
Palazestrant
Palazestrant is under investigation in clinical trial NCT06016738 (OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer).
Investigational
Flavin-adenine dinucleotide-N5-isobutyl ketone
Experimental
BBV152
BBV152 is a vaccine candidate created by the Indian Council of Medical Research (ICMR). The candidate, a whole virion inactivated SARS-CoV-2 vaccine, was developed from a well-known SARS-CoV-2 strain and a vero cell platform (CCL-81) with adjuncts of either aluminum hydroxide gel (Algel) or a novel TLR7/8 agonist adsorbed gel....
Investigational
Matched Description: … Animal studies in mice, rats, and rabbits reported BBV152 immunogenicity at two separate antigen concentrations …
Edotecarin
Edotecarin is a novel, non-camptothecin, DNA topoisomerase I inhibitor. It is member of the class of compounds called indolocarbazoles.
Investigational
Amelubant
Investigational
LCL-161
LCL161 has been used in trials studying the treatment of Leukemia, Neoplasms, Solid Tumors, Breast Cancer, and Ovarian Cancer, among others.
Investigational
ADH-503
Investigational
Allysine
Experimental
Phlorizin
Experimental
Sovesudil
Investigational
Displaying drugs 4701 - 4725 of 5128 in total